ProMIS Neurosciences PMN
NASDAQ PMN
$9.02 -0.11 (-1.20%)
As of: Oct 22, 2026 · 11:51 AM EDT

ProMIS Neurosciences (PMN) Change in Other Operating Liabilities (2021)

Updated

Analysis

ProMIS Neurosciences (PMN) Change in Other Operating Liabilities (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,170.42 Bn 1,139.01 Bn 19.71 Bn -
2 Johnson & Johnson 648.22 Bn 568.08 Bn 17.30 Bn 2.69 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn -
4 Merck 369.14 Bn 323.52 Bn 12.21 Bn -
5 Novartis Ag 303.29 Bn 267.28 Bn 11.24 Bn -
6 Astrazeneca 268.21 Bn 241.90 Bn 12.86 Bn -
7 Amgen 242.56 Bn 197.96 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn -
9 Pfizer 173.28 Bn 119.92 Bn 10.94 Bn -112.00 Mn
10 ProMIS Neurosciences 82.46 Mn -56.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -997,960.00
Sep 30, 2021 -267,276.00
API Access

ProMIS Neurosciences Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=PMN&period=max&api_key=YOUR_API_KEY